20 August 2018 – Podcast and Radio Streaming Service Ximalaya Secures $580m

Deals

With much of the western VC industry seemingly on summer holiday (and frankly, who can blame them?), it’s up to China to pick up the slack in corporate venturing. Ximalaya, the operator of a streaming platform for radio shows and podcasts, has secured $580m in a Tencent-backed round that reportedly valued it at about $3.5bn post-money.

Pfizer has provided an undisclosed amount of equity funding for immunotherapy developer Biontech as part of a collaboration agreement that could reach $425m if it reaches every milestone.

Alphabet has paid about $375m for a stake of around 10% in health insurance provider Oscar Health, which will put the funding toward beefing up its existing team.

TZero, a blockchain lending technology developer spun off from listed e-commerce firm Overstock, is raising up to $270m from GSR Capital, which is set to acquire an 18% stake in the company.

DoorDash, a last-mile delivery service for restaurants, appears to be one of the success stories of 2018. The company was valued at $1.4bn post-money when it raised $535m in a SoftBank-led round in March, but has now raised another $250m at a whopping $4bn valuation just five months later.

Orchard Therapeutics, which is working on gene therapies for rare diseases based on research at University College London, has secured $150m in a series C round that included Sphera Global and corporate venturing unit Medison Ventures.

Exabeam, a cybersecurity information and event management software provider, has raised $50m in series D cash from backers including Cisco Investments.

Funds

E-commerce firm JD.com has begun taking a more active part in corporate venturing in the past year or two, backing the likes of Traveloka, Dada-JD Daojia, Aihuishou and Go-Jek at growth stage alongside post-IPO investments in companies such as Secoo and VIPshop.

Educational services firm New Oriental Education and Technology has put together a $220m fund that will invest between $3m and $15m in early-stage education-focused startups in China.

Exits

Electric vehicle developer Nio recently began shipping its first commercial vehicle, and now it’s filed for a $1.8bn initial public offering in the US.

Babytree, the social parenting community that has branched out into e-commerce, is looking to raise between $800m and $1bn in its Hong Kong IPO, sources have told Reuters, adding that it is seeking a valuation between $3bn and $5bn in the offering.

Weidai, which runs a lending service that uses borrowers’ vehicles as collateral, has filed for a $100m IPO in the US that could give exits to corporate investors Hakim Unique, Shanda and Dong Yi Ri Sheng Home Decoration.

On GUV, Sensyne Health, a UK-based healthcare technology developer partially based on research at University of Oxford, raised £60m ($76m) in its initial public offering on Tuesday and began trading on Aim on Friday.

And Quethera, a UK-based glaucoma therapy developer spun out from University of Cambridge, has been acquired by pharmaceutical firm Astellas Pharma for up to $108m in cash and contingent commitments.

And a nice exit for corporate, university and government venturing entities was Millendo Therapeutics, a US-based endocrine disease drug spinout of University of Michigan, which agreed to a reverse merger with US-listed fertility treatment provider OvaScience.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

02 July 2018 – AT&T Agrees Acquisition of AppNexus

Exits

AT&T has agreed an acquisition of AppNexus reported to be priced around the $1.6bn mark, enabling WPP, Microsoft, News Corp and Deutsche Telekom to exit.

PayPal sinks $120m into Simility acquisition

University

TTTech sells stake to B&C

Xiaomi’s IPO has been a long, hard slog for the company. It had originally aimed to raise $10bn in a dual Hong Kong and Shanghai listing that would have valued it at about $100bn, but the Qualcomm-backed electronics producer has had to settle for a $4.7bn offering, solely in Hong Kong, which valued it at $54bn.

Chinese automotive e-commerce marketplace Cango has filed to raise up to $300m in a US-based initial public offering that will allow Tencent, Didi Chuxing and Taikang Life Insurance to exit.

A more recently thriving space involves livestreaming, and China-based Inke has set the terms for an initial public offering in Hong Kong that will net $167m if it floats at the top of the range.

Babytree, a China-based online platform that combines baby and child products, development advice and social networking for parents, has filed for an IPO in its home country.

Outside of China, life sciences companies are driving the US IPO surge, much as they did three three or four years ago. Some half dozen healthcare companies floated the previous week including Magenta Therapeutics, which secured $100m when it floated.

Cancer drug developer Constellation Pharmaceuticals has filed to raise up to $86.3m in an offering that will follow almost $230m in equity funding.

Translate Bio, a developer of messenger RNA drugs for diseases caused by gene or protein dysfunction, has raised over $121m in its own IPO, in the US.

Neon shows way to $100m IPO

Kezar kicks into public markets

Xeris reformulates path to IPO

ElectroCore enters public markets with $78m offering

Allakos aligns itself with $75m IPO

Deals

Transport services provider Go-Jek closed a $1.5bn round earlier this year at a $4.8bn valuation, and is now in talks to raise the same amount in a new round, according to The Information.

Evergrande Health Industry, part of property developer China Evergrande, has taken a 45% stake in smart electric vehicle developer Faraday Future, paying $860m for Season Smart, the investment entity that held a 45% stake in the company.

Showing once again that ride hailing continues to be a vibrant destination for venture funding, Lyft has raised $600m in a Fidelity-led round that valued it at more than $15bn post-money.

PolicyBazaar signs up SoftBank for $238m round

Helix has closed a series B round backed by Illumina and Mayo Clinic at $200m, and will use the funding to expand its personal genomics product marketplace.

Precision BioSciences has closed a $110m series B round backed by Amgen Ventures, Brace Pharma Capital and Alexandria Venture Investments, and will use the proceeds to expand the portfolio of products centred on its genome editing platform.

Advanced battery developer QuantumScape has largely operated in stealth since it was founded in 2010 but has received $100m from Volkswagen as part of a deal that will involve the companies forming a joint venture to bring solid-state batteries to the industrial-scale manufacturing stage by 2025.

AISpeech aces latest round

Cibus harvests $70m in series C funding

B-Stock beats its way to $65m

TouchBistro completes $54m series D order

Carisma charms investors in $53m series A

AIpark finds space for Nio in series B

University

Pennsylvania lines up $50m

Irish spinout generation slides in 2017

Funds

Dementia Discovery Fund delivers $350m close

Charles University spawns TTO


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0